scispace - formally typeset
N

Nina A. Bickell

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  121
Citations -  3891

Nina A. Bickell is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 31, co-authored 106 publications receiving 3474 citations. Previous affiliations of Nina A. Bickell include New York State Department of Health & Harvard University.

Papers
More filters
Journal ArticleDOI

Missed Opportunities: Racial Disparities in Adjuvant Breast Cancer Treatment

TL;DR: Minority women with early-stage breast cancer have double the risk of white women for failing to receive necessary adjuvant treatments despite rates of oncologic consultation similar to those for white women.
Journal ArticleDOI

Language barriers in medicine in the United States.

TL;DR: It is through language that physicians and patients achieve an empathic connection that may be therapeutic in itself and millions of US residents cannot have this connection with their physician because of language barriers.
Journal ArticleDOI

How Time Affects the Risk of Rupture in Appendicitis

TL;DR: Physicians should be cautious about delaying surgery beyond 36 hours from symptom onset in patients with appendicitis and risk of rupture in ensuing 12-hour periods rises to 5% after 36 hours of untreated symptoms.
Journal ArticleDOI

Hospital volume differences and five-year survival from breast cancer

TL;DR: Hospital volume of breast cancer surgical cases has a strong positive effect on 5-year survival, and research is needed to identify whether processes of care, especially postsurgical adjuvant treatments, contribute to survival differences.
Journal ArticleDOI

Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment?

TL;DR: Women are less likely than men to be referred for coronary bypass graft surgery among patients with a low risk for cardiac death, in whom surgery offers little or no survival benefit over medical treatment, and these referral patterns may represent more appropriate treatment referral for women than men.